Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Afalaza

Safety and Efficacy

DRUG

Placebo

Safety and Efficacy

Trial Locations (16)

109472

"The State Budget Health Care institution of Moscow the City Hospital for veterans of wars No. 2 of the Administration of Health Care of Moscow City", Moscow

115419

"The State Budget Health Care institution of Moscow the City Specialized clinical (neuro-psychiatric) hospital No. 8 n.a. Z.P. Solovyov - ''Clinic of neuroses of the Administration of Health Care of Moscow City", Moscow

117198

"The Federal State Budget Educational institution of High Professional Training Peoples' Friendship University of Russia, Department of Urology and Operative Nephrology", Moscow

119991

The State Budget Educational institution of High Professional Training I.M. Sechenov First Moscow State Medical University of Ministry of Health Care and Social Development of the Russian Federation, Department of Urology, Moscow

127473

"The State Budgetary Educational Institution of Higher Professional Education Moscow State University of Medicine and Dentistry of A. I. Evdokimov Ministry of Health of the Russian Federation", Moscow

129090

"The Federal State Budget institution Polyclinic № 3 of Affairs Management Department of the President of the Russian Federation", Moscow

141060

"Limited liability company Family Policlinic No. 4", Moscow Region Koroljov

191036

"The Federal State Budgetary Institution Saint-Petersburg Research Institute Phthisiopulmonology Ministry of Health of the Russian Federation", Saint Petersburg

194044

"The Federal State institution All-Russian center of emergency and radiation medicine n.a. A.M. Nikiforov of the Ministry of the Russian Federation for Affairs of civil defence, emergencies and elimination of consequences of natural disasters", Saint Petersburg

194291

"The Federal State Budgetary Health Care Institution Clinical Hospital №122 n. a. L. G. Sokolov of the Federal Biomedical Agency", Saint Petersburg

196066

"Limited liability company Medical unit No. 157", Saint Petersburg

199106

"Saint-Petersburg State Budget Health Care institution Pokrovsky city hospital", Saint Petersburg

199178

"Limited Liability Company Hospital OrCli", Saint Petersburg

344011

"Municipal Treatment-and-Prophylactic Health Care institution Clinical Diagnostic Centre Zdorovie", Rostov-on-Don

634050

"The State Budgetary Educational Institution of Higher Professional Education Siberian state Medical University Ministry of Health of the Russian Federation", Tomsk

04053

"The State Institution Institute of Urology of the Ukraine National Academy of Medical Sciences", Kyiv

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT01716104 - Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression | Biotech Hunter | Biotech Hunter